NPR’s Rob Stein was reporting on what he described as “among the most exciting developments in cancer research in years” — a ...

CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...

Our immune system is designed to protect us by recognizing and attacking infected or abnormal cells. However, cancer cells ...

JNJ-79635322 shows favorable responses and manageable safety in BCMA/GPRC5D-naïve patients with relapsed/refractory multiple ...

The interim data, with a cutoff date of April 11, 2025, showed an impressive 70% CR rate. Prior to NXC-201 treatment, the ...

Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...

Chimeric Antigen Receptor or CAR T-cell therapy, the groundbreaking method of treatment, has given new hope to cancer ...

A LIVING cancer drug has been proven to work against solid tumours for the first time. Immune-boosting CAR-T therapy removes ...

Holdings announces two previously announced U.S. patent applications have been granted by the U.S. Patent and Trademark ...

Researchers sought to determine whether the ALL-Hematotox would be able to predict hematotoxicity for patients with B-ALL who are at risk of severe hematotoxicity following CAR-T therapy.

Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy ...

CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...